Clinical Trials

April 16, 2025

Understanding how ROR1-targeted therapies work—and whether they apply to your specific blood cancer type—can help you make more informed treatment decisions.

February 19, 2025

What clinical trials have shaped the way that we view and use minimal residual disease testing in multiple myeloma?

January 24, 2025

People with precursor conditions to myeloma wonder if diet can help prevent progression to cancer. Learn more from a recent study.

October 14, 2024

Learn about anitocabtagene autoleucel, a new CAR-T treatment for relapsed myeloma patients, showing promising results in Phase I trials.

August 29, 2024

Explore how yoga can improve physical and mental health for myeloma patients in a national clinical trial by the University of Arizona.

June 21, 2024

Learn about a new BCMA-directed bispecific antibody called ABBV-383, administered to relapsed/refractory myeloma patients in a clinical trial.

May 21, 2024

The Use of Bispecifics And CAR-T In Myeloma Treatment

May 07, 2024

Watch our interview with Dr. Kaur. She shared the comprehensive myeloma research program at UT Southwestern.

April 26, 2024

Learn about ORIC-533, a potential new oral treatment for myeloma. Understand how it works, early clinical trial results, and the future outlook for this drug.

April 18, 2024

Simmons Cancer Center leads Myeloma research with CAR-T, stem cells & more. Learn about GPRC5D targeting, Tregs, bispecific antibodies & upcoming trials.